190 related articles for article (PubMed ID: 6238730)
1. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
Inui K; Wenger DA
Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
3. Use of 4-methylumbelliferyl-6-sulpho-2-acetamido-2-deoxy-beta- D-glucopyranoside for prenatal diagnosis of Tay-Sachs disease using chorionic villi.
Grebner EE; Wenger DA
Prenat Diagn; 1987 Jul; 7(6):419-23. PubMed ID: 2958791
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of GM2 gangliosidoses using a fluorogenic sulfated substrate.
Inui K; Wenger DA; Furukawa M; Suehara N; Yutaka Y; Okada S; Tanizawa O; Yabuuchi H
Clin Chim Acta; 1986 Jan; 154(2):145-50. PubMed ID: 3955840
[No Abstract] [Full Text] [Related]
5. Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.
Ben-Yoseph Y; Reid JE; Shapiro B; Nadler HL
Am J Hum Genet; 1985 Jul; 37(4):733-40. PubMed ID: 9556661
[TBL] [Abstract][Full Text] [Related]
6. Sandhoff disease: a prevalent form of infantile GM2 gangliosidosis in Lebanon.
Der Kaloustian VM; Khoury MJ; Hallal R; Idriss ZH; Deeb ME; Wakid NW; Haddad FS
Am J Hum Genet; 1981 Jan; 33(1):85-9. PubMed ID: 7468596
[TBL] [Abstract][Full Text] [Related]
7. Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.
Kytzia HJ; Hinrichs U; Maire I; Suzuki K; Sandhoff K
EMBO J; 1983; 2(7):1201-5. PubMed ID: 6226523
[TBL] [Abstract][Full Text] [Related]
8. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
Charrow J; Inui K; Wenger DA
Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid.
Yamato O; Satoh H; Matsuki N; Ono K; Yamasaki M; Maede Y
J Vet Diagn Invest; 2004 Jan; 16(1):39-44. PubMed ID: 14974845
[TBL] [Abstract][Full Text] [Related]
11. Chromatofocusing coupled with automated assay for beta-hexosaminidase isoenzymes in GM2 gangliosidosis.
Orlacchio A; Maffei C; Emiliani C; Coppa GV; Felici L
Experientia; 1985 Apr; 41(4):525-7. PubMed ID: 3157597
[TBL] [Abstract][Full Text] [Related]
12. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
Peleg L; Goldman B
Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
[TBL] [Abstract][Full Text] [Related]
13. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
Christopher R; Rangaswamy GR; Shetty KT
Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
[TBL] [Abstract][Full Text] [Related]
14. GM2-gangliosidosis. Clinical and biochemical aspects of four cases.
Praamstra P; Wevers RA; Gabreëls FJ; Rotteveel JJ; Renier WO; Sengers RC; Lamers KJ
Clin Neurol Neurosurg; 1990; 92(2):143-8. PubMed ID: 2163796
[TBL] [Abstract][Full Text] [Related]
15. Plasma G
Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
[TBL] [Abstract][Full Text] [Related]
16. Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
Chamoles NA; Blanco M; Gaggioli D; Casentini C
Clin Chim Acta; 2002 Apr; 318(1-2):133-7. PubMed ID: 11880123
[TBL] [Abstract][Full Text] [Related]
17. In situ assessment of beta-hexosaminidase activity.
Lacorazza HD; Jendoubi M
Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
[TBL] [Abstract][Full Text] [Related]
18. Molecular forms of beta-N-acetylhexosaminidase in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with Tay-Sachs disease.
Salvayre R; Maret A; Negre A; Lenoir G; Vuillaume M; Icart J; Didier J; Douste-Blazy L
Eur J Biochem; 1983 Jul; 133(3):627-33. PubMed ID: 6305653
[TBL] [Abstract][Full Text] [Related]
19. Identification of Sandhoff disease in a Thai family: clinical and biochemical characterization.
Sakpichaisakul K; Taeranawich P; Nitiapinyasakul A; Sirisopikun T
J Med Assoc Thai; 2010 Sep; 93(9):1088-92. PubMed ID: 20873083
[TBL] [Abstract][Full Text] [Related]
20. [Sandhoff's and Tay-Sachs disease--based on our own cases].
Kokot W; Raczyńska K; Krajka-Lauer J; Iwaszkiewicz-Bilikiewicz B; Wierzba J
Klin Oczna; 2004; 106(3 Suppl):534-6. PubMed ID: 15636260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]